Citation Tools
PDFRegular and young investigator award abstracts
Novel single-agent immunotherapies
711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda